SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Antex Biologics (ANTX)
ANTX 1.090-2.7%11:14 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Albert Martin who wrote (756)3/10/1998 6:04:00 PM
From: John R Resseger  Read Replies (1) of 1476
 
Albert

The units contain one share of stock and one warrant to buy one share of stock at 50 cents.

barington.com

Barington has 2 years to purchase the units after 3-26-98

SKB is committed to funding for several more years, so a merger with Glaxo is not going to effect that.

SKB had an option to increase their share of the joint venture last October. They were big hearted enough to ask Antex what they wanted SKB to do! Antex said we would prefer you not increase your share in the JV. There is one more oportunety for SKB to increase their J V share. Oct. 1 1998. Under Glaxo, SKB might not ask Antex what they desire.

Albert The current obsession with large cap stocks where Merck is valued at $135,000,000,000 vs Antex $28,000,000 will if not modified only prevent Antex from more quickly exploiting their technologies in more areas. I think they have the money and backing to push forward with everything on the plate. With a lot more money they have a lot more areas they could pursue.

This is one of many stocks I have owned at $1 that can or Has gone to $50 VTSS JCOR DY I only hope I have the discipline to hold on to most of what I have. The new capital gains rules encourage that sort of thing.

John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext